
Orri Bjornsson Chief Executive Officer

Algalif Revolutionizing Nutrition the Eco-Friendly Way
Seeing the opportunity for growth in a relatively new industry, entrepreneur Orri Björnsson became the leader of infant startup Algalif in 2013. Today, Algalif a part of Sana Pharma Holding, is a major player in the European Biotechnology sector and a global leader in the production of sustainable micro algae.
A Brief Background about Algalif
Seeing the opportunity for growth in a relatively new industry, entrepreneur Orri Björnsson became the leader of infant startup Algalif in 2013. Today, Algalif a part of Sana Pharma Holding, is a major player in the European Biotechnology sector and a global leader in the production of sustainable micro algae.
Vision and mission of the company
Headquartered in Reykjanesbaer, Iceland, Algalif specializes in creating food supplements containing Astaxanthin. Astaxanthin, which is extracted from the Haematococcus pluvialis species of microalgae, possesses various health benefits. Among the long list of positive results it imparts to one’s health, Astaxanthin can do wonders for a consumer’s cardiovascular system and the longevity of their muscular health.
Algalif produces the basic ingredients for nutritional products that range from gelatin capsules to oil-based cosmetics. Each product contains the beforementioned astaxanthin compound. The company differs from other biotechnology companies in that they carry out all production activities by maintaining the highest standards of Quality, Safety, and Sustainability.
Along with the Astaxanthin supplements, the company also offers immune boosters named Nutramunity Beta-Glucan.
These supplements are used in a variety of consumables and care products, especially by athletes and people over 50.
Given that a big part of the company’s customer base comprises athletes, Algalif has made it a point to support local sports and other community-related activities.
Algalif works in the spirit of the UN Global Goals.
Algalif is beyond Zero Carbon Footprint, follows a strict Zero Waste policy, minimizes the use of land, water and other natural resources and works with its local society and its employees to create a more sustainable environment.
Functioning of Algalif
Joining this company would mean working alongside a small-knit group of individuals passionate about biotechnology and bettering human health.
A typical day at the office will involve handling state-of-the-art technology that ensures compliance with cGMP protocols. The facility holds a unique photobiotic reactor cultivation system that can protect the algae from contamination or undesirable temperatures.
Algalif is committed to providing a reliable supply of high-quality, pure, sustainable astaxanthin from algae. Their indoor production process design is formulated to deliver high yields of premium astaxanthin using pure Icelandic water and renewable energy. The company ensures that the energy that powers all production activities comes from 100% renewable sources and uses only geothermal energy from a nearby power plant.
Leaders behind the success of Algalif
The brain behind Algalif´s succsess and incorporating sustainable practices is the CEO Orri Björnsson. Beginning his career in 2002, Björnsson worked at Actavis and AMSCO. His time at AMSCO allowed him to learn about implementing environmentally safe practices in the manufacturing process and the benefits. Björnsson has spent around 20 years in the pharmaceutical and biotechincal industries, most of his time serving Algalif. He is the entreprenaur spirit that drives the highly skilled team of experts towards the goal of industry excellence and superb quality products.
Awards and honors
Algalif has become one of the leading producers of nutritional supplements in the whole of Europe. In fact, at the 2021 GHP Biotechnology Awards, the company was applauded for being the best Natural Astaxanthin Products Supplier in the world. The award honored the environmental policy implemented by Algalif, showcasing it as one of the most sustainable companies in the biotechnology and nutrition sector
Future scope of Algalif
Recently, the Algalif management has approved a massive business expansion plan by investing $30 million. As per this plan, a new facility will be established, which will increase production by three times its previous limit by 2023. To put that in perspective, Algalif previously produced a total of 1,500 kgs of high-quality Astaxanthin. With the construction of the new factory, the company will be churning out 5,000 kgs of Astaxanthin, having the same quality, per year. The expansion will also create new job opportunities for the local inhabitants. The company will also be able to add more permanent employees to its fleet of managers. Construction has already started and the new factory will be up and running by 2023.
Thus, the future seems optimistic for Algalif as they continue to gain popularity in Europe and globally. The company, which has seen tremendous growth in such a short span of 9 years, has charted a success path for the coming years. With the construction of a brand new factory, Algalif is set to create history in the global marketplace.